American Well Corporation

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AMWL reports Q4 achievements, eyes revenue growth through Converge

AMWL's Q4 performance highlighted achievements in client migrations and strategic partnerships, with a focus on revenue growth for 2023.
Strengths include ACV growth, strong demand for behavioral health solutions, and the potential of the Converge platform to drive integration.
Challenges lie in revenue outlook impacted by customer churn, while opportunities exist in driving growth through Converge and service revenue.
Despite uncertainties, AMWL remains confident in its position in the digital care market and readiness to capitalize on market opportunities.

American Well (AMWL) reports Q1 growth amid margin challenges

AMWL's Q1 performance showed revenue growth but challenges in margins due to operational factors.
The company's focus on customer relationships and solution-based sales strategy are key strengths.
Opportunities lie in leveraging subscription revenue, market receptivity, and a strong financial position for future growth.
Challenges include margin pressures, limited growth avenues without mergers, and market scrutiny on key operational metrics.

American Well (AMWL) excels in Q2 with Converge migrations and international partnerships

AMWL's Q2 performance showcased strong client migrations, new wins, and international partnerships, with a focus on profitability.
Converge's modularity and end-to-end experience drive efficiency and positive renewals, while challenges include managing churn and pricing.
Opportunities in successful client migrations, market shift towards production platforms, and behavioral health integration are key growth areas.
Efforts to simplify the customer journey and accelerate ROI realization through modular approaches are underway for AMWL.

AMWL excels in Q3 with government wins and strategic partnerships

American Well Corporation's Q3 earnings call highlighted strong performance, strategic wins, and operational improvements positioning the company for future growth.
While facing challenges with legacy platforms, AMWL's focus on Converge, cost savings, and client engagement presents opportunities for enhanced profitability.
With a clear roadmap for growth and a focus on customer-centric solutions, AMWL is poised for significant revenue expansion and margin improvement in the coming years.

AMWL reports solid Q4 performance, eyes revenue growth opportunities

AMWL's Q4 performance reflects strategic advancements, high client satisfaction, and revenue diversification, positioning the company for future growth.
While facing challenges in achieving breakeven EBITDA and addressing subscription revenue declines, AMWL's strengths in market traction and sales model transformation offer growth opportunities.
Guidance for 2024 and 2025 outlines a clear path towards revenue growth, improved EBITDA, and leveraging Converge for enhanced customer value and revenue generation.

American Well (AMWL) reports strong Q1 growth and eyes retail expansion

American Well's Q1 performance showcased growth and cost structure improvements, with a focus on subscription revenue.
The company's strategic initiatives target efficiency improvements and higher-margin software subscriptions.
Opportunities lie in market shifts towards complete healthcare solutions and expansion with existing customers.
Challenges include cost initiatives towards profitability and addressing impacts of lower subscription software revenue.

American Well Corp. reports revenue growth and boosts EBITDA guidance

AMWL's Q2 2024 performance reflects positive revenue growth, improved gross profit margin, and adjusted EBITDA guidance raise, underlining the company's progress.
While facing challenges in achieving positive EBITDA and operational efficiency, AMWL's strengths in customer relationships, cost-cutting measures, and market positioning offer strategic advantages.
Opportunities for AMWL include optimizing spend, expanding client base, and leveraging its unique position in the digital healthcare market to drive future growth and profitability.

American Well Corp reports Q3 growth and strategic positioning

American Well Corporation (AMWL) demonstrated steady revenue growth and a commitment to strategic initiatives in Q3 2024.
While facing challenges in achieving profitability, the company's focus on cost alignment and growth positioning bodes well for future performance.
Opportunities in leveraging key contracts and subscription revenue growth position AMWL for continued success in the healthcare technology sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BOSTON--(BUSINESS WIRE)--Amwell to Report Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, Nov. 1, 2023.

Amwell to Report Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, Nov. 1, 2023

BOSTON & JOHANNESBURG--(BUSINESS WIRE)--Amwell partners with Discovery Health to bring first-of-its-kind digital mental health benefit to South Africa.

Amwell® Partners With Discovery Health to Bring First-of-its-Kind Digital Mental Health Benefit to South Africa

BOSTON--(BUSINESS WIRE)--Nestlé Health Science Collaborates with Amwell® to Improve Nutrition Outcomes in Healthcare.

Nestlé Health Science Collaborates With Amwell® to Improve Nutrition Outcomes in Healthcare

BOSTON--(BUSINESS WIRE)--Amwell leaders and clients will participate in several speaking events discussing the future of hybrid care.

Amwell® to Participate in Key HLTH 2023 Engagements

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--With a more connected and efficient digital lab process, Health Gorilla and Amwell reinforce their commitment to accessible hybrid care.

Health Gorilla and Amwell Announce Expanded Digital Diagnostic Lab Ordering for Clinicians

BOSTON--(BUSINESS WIRE)--Leaders from Aultman Health, Banner Health and Children's National Hospital to share successes with Amwell platforms and Oracle Health integration.

Three Amwell® Health System Clients to Lead Hybrid Care Panel at Oracle Health Conference

BOSTON--(BUSINESS WIRE)--OSF HealthCare Reduces Rates of Depression and Anxiety by over 50% using the Amwell® Platform.

OSF HealthCare Reduces Rates of Depression and Anxiety by Over 50% Using the Amwell® Platform

The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

American Well Corporation (AMWL) Reports Q2 Earnings: What Key Metrics Have to Say

American Well Corporation (NYSE:AMWL ) Q2 2023 Earnings Conference Call August 2, 2023 5:00 PM ET Company Participants Sue Dooley - Head of IR Ido Schoenberg - Chairman and CEO Bob Shepardson - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley Jack Wallace - Guggenheim Securities Stan Bernstein - Wells Fargo Securities Glen Santangelo - Jefferies Charles Rhyee - TD Cowen Alan Lutz - Bank of America Merrill Lynch Operator Good afternoon. My name is David and I'll be your conference operator today.

American Well Corporation (AMWL) Q2 2023 Earnings Call Transcript

American Well Corporation (AMWL) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.25 per share a year ago.

American Well Corporation (AMWL) Reports Q2 Loss, Lags Revenue Estimates

BOSTON--(BUSINESS WIRE)--AMWL Q223 Earnings Release.

Amwell Announces Results for Second Quarter 2023

BOSTON--(BUSINESS WIRE)--Q223 Earnings Save the Date.

Amwell to Report Second Quarter 2023 Operating Results and Host Conference Call on Wed., Aug. 2, 2023

BOSTON--(BUSINESS WIRE)--2023 Mental Health Employer Survey.

Amwell Survey Identifies Workers' Top Barriers to Accessing Mental Health Benefits

BOSTON--(BUSINESS WIRE)--Amwell Announces Hire of Kathy Weiler as EVP, Chief Commercial and Growth Officer.

Amwell Announces Hire of Kathy Weiler as EVP, Chief Commercial and Growth Officer

American Well Corporation (NYSE:AMWL ) Q1 2023 Results Conference Call May 3, 2023 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Alan Lutz - Bank of America Lucas Romanski - TD Cowen Jack Wallace - Guggenheim Matthew Shea - Needham Glen Santangelo - Jefferies Stan Bernstein - Wells Fargo Jonathan Young - Credit Suisse Eric Percher - Nephron Operator Good evening. My name is Emma and I will be your conference operator for today.

American Well Corporation (AMWL) Q1 2023 Earnings Call Transcript

American Well Corporation (AMWL) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.26 per share a year ago.

American Well Corporation (AMWL) Reports Q1 Loss, Lags Revenue Estimates

BOSTON--(BUSINESS WIRE)--AMWELL ANNOUNCES RESULTS FOR FIRST QUARTER 2023.

Amwell Announces Results for First Quarter 2023

BOSTON--(BUSINESS WIRE)--Amwell to Report First Quarter 2023 Operating Results and Host Conference Call on Wed.

Amwell to Report First Quarter 2023 Operating Results and Host Conference Call on Wed., May 3, 2023

B2Gold

Ammo

Super Group SGHC Ltd

Solid Power

Tilray Brands

Uranium Energy

Before entertaining the discussion of the top penny stocks to watch, it is imperative to emphasize that this market arena requires caution before investing. It looks as if 2023 could be a prosperous year for stocks.

7 Penny Stocks to Keep an Eye on for the Rest of the Year

DarioHealth

New agreement integrates Dario's cardiometabolic suite into Amwell's market leading digital care delivery enablement platform covering over 90 million lives NEW YORK , March 22, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today a strategic partnership with Amwell ® (NYSE: AMWL), a leader in digital healthcare enablement, to deliver its cardiometabolic solution to Amwell customers. Dario's solution will be available through Amwell beginning in the second half of 2023.

Dario Announces Strategic Partnership with Amwell to Expand Access to its Cardiometabolic Digital Therapeutic Solution

BOSTON--(BUSINESS WIRE)--Amwell® (NYSE: AMWL), a leader in digital healthcare enablement, today announced the expansion of its digital clinical programs to include a cardiometabolic program, enabling health plans and clinicians to seamlessly connect members living with common chronic diseases, such as diabetes and high blood pressure, to Dario's highly personalized digital therapeutic solution on the Amwell platform.

Amwell Expands Digital Clinical Programs Through Partnership with DarioHealth

The fallout continued from the company's fourth-quarter and full-year 2022 earnings release.

Why American Well Stock Tumbled This Week

American Well Corporation (NYSE:AMWL ) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Co-Chief Executive Officer Bob Shepardson - Chief Financial Officer Conference Call Participants Lucas Romanski - Cowen Matthew Shea - Needham & Company Craig Hettenbach - Morgan Stanley Jack Wallace - Guggenheim Securities Hanna Lee - Bank of America Dolph Warburton - Nephron Research David Larsen - BTIG Operator Good evening. My name is Savannah and I will be your conference operator for today.

American Well Corporation (AMWL) Q4 2022 Earnings Call Transcript

BOSTON--(BUSINESS WIRE)--Amwell, a leader in digital healthcare enablement, today announced financial results for the fourth quarter and full year ended December 31, 2022.

Amwell Announces Results for Fourth Quarter and Full Year 2022

Denison Mines

Orla Mining Ltd. 

RLX Technology

Before discussing the most promising penny stocks to buy, it's important to broadcast a fundamental disclaimer: this sector is wildly risky. As an investor, you want to make sure the bulk of your money goes toward higher-probability names.

News for American Well Corporation Stock (AMWL)